FDA authorizes breath test that can detect COVID-19 in three minutes

The Food and Drug Administration has granted emergency use authorization to a new COVID-19 test that can detect infections with only a sample of a patient's breath, using a device that can yield results in less than three minutes. 

The agency says the InspectIR COVID-19 Breathalyzer will only be available for tests "by a qualified, trained operator under the supervision of a health care provider." 

"The FDA continues to support the development of novel COVID-19 tests with the goal of advancing technologies that can help address the current pandemic and better position the U.S. for the next public health emergency," Dr. Jeff Shuren, the FDA's top COVID-19 testing official, said in a statement announcing the authorization.